Matches in Wikidata for { <http://www.wikidata.org/entity/Q91526900> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q91526900 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91526900 description "scientific article published on 01 July 2019" @default.
- Q91526900 description "wetenschappelijk artikel" @default.
- Q91526900 description "наукова стаття, опублікована 1 липня 2019" @default.
- Q91526900 name "Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation" @default.
- Q91526900 name "Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation" @default.
- Q91526900 type Item @default.
- Q91526900 label "Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation" @default.
- Q91526900 label "Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation" @default.
- Q91526900 prefLabel "Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation" @default.
- Q91526900 prefLabel "Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation" @default.
- Q91526900 P1433 Q91526900-701D5F30-FFD1-4980-B7EF-20215D79AA4A @default.
- Q91526900 P1476 Q91526900-10C2B410-7C16-443D-B83F-DBFA213E1563 @default.
- Q91526900 P2093 Q91526900-019D194B-3A7C-47A3-8D7C-8748AB5704B6 @default.
- Q91526900 P2093 Q91526900-1CFE9779-316B-4B7D-A947-6D29D290CE1C @default.
- Q91526900 P2093 Q91526900-3EC9FF7F-41C3-434D-AFA4-B74BC63B7FF3 @default.
- Q91526900 P2093 Q91526900-42274BBA-A748-4B9F-9666-2456F4105481 @default.
- Q91526900 P2093 Q91526900-5C709293-0C24-46B6-BFE8-09242B1A8929 @default.
- Q91526900 P2093 Q91526900-6D15DD7C-7915-48BA-9B4E-36FE6A3D6DB1 @default.
- Q91526900 P2093 Q91526900-7F117E4A-C52A-47D8-9A9E-D00AAFA37FF8 @default.
- Q91526900 P2093 Q91526900-CD1A21DB-A8FE-45B3-BF09-0AFF0D9BB222 @default.
- Q91526900 P304 Q91526900-DB29EF46-6DBE-4673-AA7D-9285EF8FD1ED @default.
- Q91526900 P31 Q91526900-71C5D645-3DC4-490B-AFDA-B0BA9F132565 @default.
- Q91526900 P356 Q91526900-11DC0546-EA76-4D80-9BD3-151E1CE1B959 @default.
- Q91526900 P433 Q91526900-84CDC2A7-207C-45D9-A018-AF29C7BDB641 @default.
- Q91526900 P478 Q91526900-8A38D944-4AE4-4CE0-8C71-A0013713FF8B @default.
- Q91526900 P577 Q91526900-9E716446-1EB0-4E95-8EB4-1A156F7F1FAA @default.
- Q91526900 P698 Q91526900-1D391D65-E764-4A52-B7B8-817B15EFD0FE @default.
- Q91526900 P921 Q91526900-16A89653-6610-4CC8-94A1-409A464F2C7B @default.
- Q91526900 P356 ANTICANRES.13494 @default.
- Q91526900 P698 31262872 @default.
- Q91526900 P1433 Q326290 @default.
- Q91526900 P1476 "Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation" @default.
- Q91526900 P2093 "Fumio Fukai" @default.
- Q91526900 P2093 "Hiroaki Kodama" @default.
- Q91526900 P2093 "Kazuki Otsuka" @default.
- Q91526900 P2093 "Manabu Sasada" @default.
- Q91526900 P2093 "Takuya Iyoda" @default.
- Q91526900 P2093 "Y U Hirano" @default.
- Q91526900 P2093 "Yoshikazu Higami" @default.
- Q91526900 P2093 "Yusuke Nohara" @default.
- Q91526900 P304 "3487-3492" @default.
- Q91526900 P31 Q13442814 @default.
- Q91526900 P356 "10.21873/ANTICANRES.13494" @default.
- Q91526900 P433 "7" @default.
- Q91526900 P478 "39" @default.
- Q91526900 P577 "2019-07-01T00:00:00Z" @default.
- Q91526900 P698 "31262872" @default.
- Q91526900 P921 Q938205 @default.